analytica Lab India 2026: Hyderabad Sets a New Benchmark for Lab Technology

analytica Lab India 2026 has concluded its most expansive edition yet at the HITEX Exhibition Centre, bringing together the analytical and laboratory sectors for three days of commercial networking, scientific exchange, and technology assessment.

Held from 10-12 September, the standalone event hosted 327 exhibitors from more than 15 countries and attracted 15,130 visitors. With over 10,000 products on display—ranging from diagnostics and biotechnology to analytical and laboratory technology—the event served as a comprehensive showcase. More than 100 new product launches provided researchers, procurement experts, quality teams, and business leaders with a direct look at the latest innovations entering the Indian market.

The exhibition was inaugurated in the presence of Avisha Desai, Executive Director - IMEA & Consumer & Capital Goods Unit, Messe Muenchen India; Ravindranath Cherukuri, President, Indian Analytical Instruments Association; Sarvesh Singh, Director & CEO, Telangana Lifesciences, Government of Telangana; Amita Desai, Honorary Consul and Head of Mission of Germany in Hyderabad; Madan Mohan Reddy, Director, Aurobindo Pharma Limited; K. V. Rambabu, Founder & Managing Director, Pulse Pharmaceuticals Pvt. Ltd. and Chairman, Indian Drug Manufacturers Association (IDMA) Telangana Chapter, Dr. Pravin Khullar, President, Goa Pharmaceutical Manufacturers’ Association; and Tuğçe Gül, Commercial Attaché, Trade/Commercial Office, Republic of Türkiye.

A full venue organised around laboratory decisions

The 2026 edition’s scale underscored the significant demand across the pharmaceutical, research, testing, and quality control sectors. By gathering laboratory equipment, instruments, consumables, and diagnostics in one location, the event enabled attendees to compare solutions, assess application suitability, and engage in technical dialogues with suppliers.

"The value of a trade fair is measured by the decisions it helps move forward. In Hyderabad, laboratory users arrived with defined analytical, quality and research requirements, while exhibitors brought technologies that could be examined and discussed in detail. The scale of this edition is significant because it translated into deeper technical engagement and a stronger pipeline of business conversations across India’s laboratory and life-sciences ecosystem," said Bhupinder Singh, President - IMEA, Messe München, and CEO, Messe Muenchen India.

"Telangana’s pharmaceutical and life-sciences ecosystem continues to create demand for advanced laboratory infrastructure, analytical capability and scientific talent. An international platform of this scale gives companies in the region direct access to technologies and expertise that can support research, quality and future growth," mentioned Sarvesh Singh, Director & CEO, Telangana Lifesciences, Government of Telangana.

Live Experiment Arena moves the conversation from display to evidence

For the first time at analytica Lab India, the Live Experiment Arena featured a daily schedule of demonstrations. Inkarp showcased rapid, consumable-free microvolume quantification of proteins, nucleic acids, and gold nanoparticle-tagged biomolecules using the Implen NanoPhotometer NP80. Spinco debuted its Autonomous Nexis LC system, while LabVIZIONS introduced a smart pipette equipped with an AI voice assistant.

Asecos highlighted the risks of improper storage and the importance of safe hazardous material handling in modern facilities. Avantor Performance Materials Pvt. Ltd. displayed VWR® PBI Air Samplers for microbial monitoring in critical environments. Carl Zeiss provided live software demonstrations focused on particulate matter testing, microscopy-based particle-size analysis, and morphology assessment.

This format offered visitors a firsthand look at three key laboratory applications: AI-assisted pipetting, autonomous liquid chromatography, and microvolume biomolecule quantification. By showcasing these technologies in action, the arena allowed technical professionals to evaluate workflows and discuss potential laboratory integration directly with exhibitors.

"The conversations at the show were highly application specific. Visitors wanted to understand sample requirements, workflow integration, validation support and service readiness before taking the discussion further. Demonstrating the solution in this environment helped us address those questions directly and identify serious opportunities for follow-up," voiced Aditya Marfatia, Co-founder and Director, Electrolab.

International participation brings global capability closer to Indian demand

International engagement remained a key highlight of the event. The China Pavilion hosted 35 companies, while the International Pavilion featured over 10 exhibitors from Germany, the Czech Republic, Taiwan, the United States, Poland, Japan, the United Kingdom, Canada and South Korea.

For international firms, Hyderabad provided a gateway to one of India’s primary life-sciences and pharmaceutical hubs. Conversely, the pavilions offered Indian visitors a streamlined way to evaluate global technologies, discuss localisation and service needs, and identify potential partners.

"India has become an important market within the global laboratory and analytical technology landscape. analytica Lab India connects international suppliers with users who understand their applications and are actively evaluating new capabilities. This exchange is essential for translating global innovation into technologies and partnerships that respond to local scientific and industrial requirements," said Susanne Groedl, Global Industry Lead analytica Shows Worldwide, Messe München GmbH.

"The exhibition gave us direct access to pharmaceutical, research and quality teams from across India. Their questions were detailed and closely linked to real laboratory applications, which helped us better understand where our technology is relevant and what the market expects in terms of support, localisation and long-term partnership," stated Andreas Schneider, Marketing Director, MMM Group, Germany.

Buyer-Seller Forum moves supplier discovery into structured discussion

The Buyer-Seller Forum facilitated connections for 620 hosted buyers, including 28 international participants. This structured environment allowed companies to enter meetings with well-defined requirements, enabling suppliers to better understand specific applications, timelines, and partnership opportunities.

"We came to India with a defined requirement and used the Buyer-Seller Forum to meet several relevant suppliers within a limited period. The meetings gave us a clearer view of technical capabilities, commercial readiness and the partners we should continue evaluating after the exhibition," said Yohannes Fisseha Weldearegay, Deputy General Manager, Addis Pharmaceutical Factory, Ethiopia.

"Our team attended with specific laboratory and quality requirements in mind. The opportunity to compare multiple suppliers under one roof helped us evaluate their application fit, service capabilities and the practical aspects of implementation. We have shortlisted a few companies for the next stage of technical and commercial discussions," mentioned Prakash Mudda, President – Corporate Projects & Operations, Micro Labs Ltd.

Conferences traced the laboratory agenda from regulation to intelligent decision-making

Day 1, held in partnership with the Indian Analytical Instruments Association, focused on India’s role as a global biotech and pharmaceutical hub. Discussions covered nitrosamine risk assessment, advanced therapies, vaccines, branded generics, and manufacturing excellence.

"India’s pharmaceutical ambitions depend on analytical systems that meet demanding standards of accuracy, traceability and regulatory confidence. The discussions connected regulation with the realities of formulation, vaccine development and manufacturing," said Ravindranath Cherukuri, President, Indian Analytical Instruments Association (IAIA).

Day 2 explored the future of smart, sustainable, and AI-driven laboratories, with sessions on quality culture, Lab 5.0, automation, digital informatics, and AI-assisted pharmaceutical investigations.

Day 3 shifted focus to pharmaceutical analytics and intelligent laboratories, discussing the reliability of AI-led decisions, the evolution of the laboratory by 2030, global drug development, and the transition from raw data to quality-driven outcomes.

The Science Unplugged podcast zone further extended these discussions, offering a direct platform for industry specialists, scientists, and business leaders. Collectively, the exhibition floor, conferences, and podcast sessions bridged the gap between technology discovery and the strategic, operational, and regulatory challenges facing the industry.